Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
May 7, 2013
The red jug revolution
Rebecca Firth, Kimberly Cooper
The Clinical Journal of Pain
|
July 16, 2011
A randomized, placebo-controlled trial of acetaminophen extended release for treatment of post-marathon muscle soreness
Mary Jane Prior, B Joseph Lavins, Kimberly Cooper
Current Opinion in Urology
|
December 20, 2002
Are stents still a useful therapy for benign prostatic hyperplasia?
Jason S Ogiste, Kimberly Cooper, Steven A Kaplan
American Journal of Therapeutics
|
November 16, 2004
Acetaminophen availability increases in Canada with no increase in the incidence of reports of inpatient hospitalizations with acetaminophen overdose and acute liver toxicity
Mary Jane Prior, Kimberly Cooper, Peter Cummins, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 27, 2017
Does cranberry have a role in catheter-associated urinary tract infections?
Dominique Thomas, Matthew Rutman, Kimberly Cooper, et al.
CNS Drugs
|
April 24, 2012
Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder
Richard H Weisler, Gahan J Pandina, Ella J Daly, et al.
CNS Drugs
|
April 20, 2022
Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant
Lysbeth Floden, Stacie Hudgens, Carol Jamieson, et al.
Health and Quality of Life Outcomes
|
May 9, 2023
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant
Carol Jamieson, Vanina Popova, Ella Daly, et al.
The International Journal of Neuropsychopharmacology
|
March 8, 2026
Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study
Christine Pinter, Michael E Thase, Roger S McIntyre, et al.
Journal of Clinical Psychopharmacology
|
December 31, 2010
Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study
Lenard A Adler, Camille Orman, H Lynn Starr, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
May 7, 2013
The red jug revolution
Rebecca Firth, Kimberly Cooper
The Clinical Journal of Pain
|
July 16, 2011
A randomized, placebo-controlled trial of acetaminophen extended release for treatment of post-marathon muscle soreness
Mary Jane Prior, B Joseph Lavins, Kimberly Cooper
Current Opinion in Urology
|
December 20, 2002
Are stents still a useful therapy for benign prostatic hyperplasia?
Jason S Ogiste, Kimberly Cooper, Steven A Kaplan
American Journal of Therapeutics
|
November 16, 2004
Acetaminophen availability increases in Canada with no increase in the incidence of reports of inpatient hospitalizations with acetaminophen overdose and acute liver toxicity
Mary Jane Prior, Kimberly Cooper, Peter Cummins, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 27, 2017
Does cranberry have a role in catheter-associated urinary tract infections?
Dominique Thomas, Matthew Rutman, Kimberly Cooper, et al.
CNS Drugs
|
April 24, 2012
Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder
Richard H Weisler, Gahan J Pandina, Ella J Daly, et al.
CNS Drugs
|
April 20, 2022
Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant
Lysbeth Floden, Stacie Hudgens, Carol Jamieson, et al.
Health and Quality of Life Outcomes
|
May 9, 2023
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant
Carol Jamieson, Vanina Popova, Ella Daly, et al.
The International Journal of Neuropsychopharmacology
|
March 8, 2026
Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study
Christine Pinter, Michael E Thase, Roger S McIntyre, et al.
Journal of Clinical Psychopharmacology
|
December 31, 2010
Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study
Lenard A Adler, Camille Orman, H Lynn Starr, et al.
Page
of 2